Abstract
Altered expression of glutamate transporter EAAT2 protein has been reported in the hippocampus of patients with temporal lobe epilepsy (TLE). Two alternative EAAT2 mRNA splice forms, one resulting from a partial retention of intron 7 (I7R), the other from a deletion of exon 9 (E9S), were previously implicated in the loss of EAAT2 protein in patients with amyotrophic lateral sclerosis. By RT-PCR we studied the occurrence of I7R and E9S in neocortical and hippocampal specimens from TLE patients and non-neurological controls. Both splice forms were found in all neocortical specimens from TLE patients (100% I7R, 100% E9S). This was significantly more than in controls (67% I7R, 60% E9S; P < 0.05). We also detected I7R and E9S in all seven motor cortex post-mortem samples from patients with amyotrophic lateral sclerosis. Within the TLE patient group, both splice variants appeared significantly more in non-sclerotic (100%), than in sclerotic hippocampi (69%, P < 0.05). These data indicate that the epileptic brain, especially that of TLE patients without hippocampal sclerosis, is highly prone to alternative EAAT2 mRNA splicing. Our data confirm that the presence of alternative EAAT2 splice forms is not disease specific.
References
May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Mar 1, 1992·Neurochemical Research·N A JanjuaA Mori
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
Jun 13, 1997·Science·K TanakaK Wada
Mar 21, 1998·Neuroscience Letters·T MeyerA C Ludolph
Apr 16, 1998·Neuron·G Bai, S A Lipton
Apr 16, 1998·Neuron·C L LinJ D Rothstein
May 19, 1998·Annals of Neurology·M AokiR H Brown
Dec 17, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·T MeyerA C Ludolph
Feb 1, 2000·Journal of Neurology·M JacksonK E Morrison
May 19, 2001·Annals of Neurology·J M FlowersC E Shaw
May 23, 2001·Progress in Neurobiology·N C Danbolt
Feb 9, 2002·Brain : a Journal of Neurology·E A ProperP N E de Graan
Feb 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Zao-zhong SuPaul B Fisher
Citations
Feb 6, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Julie FotheringhamSteven Jacobson
Dec 3, 2009·Antioxidants & Redox Signaling·Sergio Rosales-CorralGabriela Lopez-Armas
May 8, 2010·Journal of Neuropathology and Experimental Neurology·Rujin TianJames E Goldman
Oct 24, 2009·Epilepsy Research·Simon Waldbaum, Manisha Patel
Nov 6, 2007·Neuroscience·L T Macnab, D V Pow
May 23, 2007·Neurochemistry International·Amanda L Sheldon, Michael B Robinson
Nov 28, 2006·Neuroscience Letters·Tara L LauriatL Alison McInnes
Oct 20, 2006·Neurochemistry International·Tara L LauriatL Alison McInnes
Nov 23, 2006·Neurobiology of Disease·L P BjørnsenN C de Lanerolle
Mar 31, 2009·Neuroscience·S HolmsethN C Danbolt
Nov 8, 2006·British Journal of Pharmacology·P M Beart, R D O'Shea
Jan 24, 2006·Neurochemistry International·I W M BosP N E de Graan
May 14, 2014·Epilepsy Research·Mauro DiNuzzoFederico Giove
Mar 3, 2009·Epilepsy & Behavior : E&B·Ingmar Blümcke
Apr 6, 2007·Brain Research·Yuto UedaL James Willmore
Dec 9, 2010·Brain Research·Taku DoiL James Willmore
Apr 29, 2008·Neuron·Jonathon WetheringtonRay Dingledine
Apr 10, 2016·Neurobiology of Disease·Jerome ClasadonteYongjie Yang
Jan 17, 2015·Neuroscience·C SteinhäuserG Carmignoto
Aug 9, 2007·Molecular Psychiatry·T L Lauriat, L A McInnes
Sep 15, 2020·CNS Drugs·Aleksey V ZaitsevSaak V Ovsepian
Nov 23, 2016·Neurochemical Research·Jan Albrecht, Magdalena Zielińska
May 12, 2020·Frontiers in Cellular Neuroscience·Adam Armada-MoreiraSandra H Vaz
Nov 14, 2007·Neurochemical Research·Christoph MünchThomas Meyer
Feb 9, 2021·Experimental Biology and Medicine·Sheila Ms Sears, Sandra J Hewett
Jul 10, 2020·Neuroscience Letters·José Luis Castañeda-CabralMónica E Ureña-Guerrero